by Jordana Choucair | May 5, 2022 | Life Sciences
The House Energy and Commerce Committee released a user fee authorization bill that would allow regulators to revoke approval for drugs cleared through the accelerated approval program if drugmakers delay their required follow-up trials. A stronger measure from an...
by Jordana Choucair | May 5, 2022 | Life Sciences
Johnson & Johnson (J&J) filed a lawsuit Wednesday accusing pharmacy benefit manager SaveOnSP of improperly exploiting J&J’s copay assistance program, called Janssen CarePath, that pays out-of-pocket costs for patients who use some of the company’s...
by Jordana Choucair | May 5, 2022 | Mental Health
Mental telehealth startup Cerebral said it will stop prescribing Adderall and other controlled substances to treat attention deficit hyperactivity disorder for new patients. The decision came after Cerebral’s preferred pharmacy, Truepill, said it would halt...
by Jordana Choucair | May 5, 2022 | Payers
Cigna launched a new provider consult service that aims to improve outcomes for patients with cancer. The program, backed by the capabilities of the insurer’s Evernorth subsidiary, allows community oncologists to connect with cancer subspecialty experts at...
by Jordana Choucair | May 5, 2022 | Providers
A new study published in Health Affairs shows that only a small amount of physicians in Medicaid managed care plans care for Medicaid patients. Researchers found that approximately one-third of outpatient primary care and specialist physicians that contracted with...
Recent Comments